elarofiban has been researched along with proline in 1 studies
Studies (elarofiban) | Trials (elarofiban) | Recent Studies (post-2010) (elarofiban) | Studies (proline) | Trials (proline) | Recent Studies (post-2010) (proline) |
---|---|---|---|---|---|
5 | 0 | 0 | 22,134 | 520 | 5,973 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrade-Gordon, P; Cohen, JH; Costanzo, MJ; Damiano, BP; Haertlein, BJ; Hecker, LR; Hoekstra, WJ; Hulshizer, BL; Kauffman, JA; Keane, P; Maryanoff, BE; McComsey, DF; Mitchell, JA; Scott, L; Shah, RD; Yabut, SC | 1 |
1 other study(ies) available for elarofiban and proline
Article | Year |
---|---|
Potent, orally active GPIIb/IIIa antagonists containing a nipecotic acid subunit. Structure-activity studies leading to the discovery of RWJ-53308.
Topics: Administration, Oral; Animals; Area Under Curve; Biological Availability; Dogs; Magnetic Resonance Spectroscopy; Mass Spectrometry; Nipecotic Acids; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Proline; Pyridines; Structure-Activity Relationship | 1999 |